Download PDF
Homœopathic Links 2022; 35(01): 037-047
DOI: 10.1055/s-0042-1742591
Review Article

Exploring the Molecular Mechanism of Homoeopathic Medicines against Cancer: A Pragmatic Approach with Narrative Review of Cell Line Studies

Ashish Kumar Dixit 
1   Department of AYUSH, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
,
Sukhes Mukherjee
2   Department of Biochemistry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
,
Danish Javed 
3   Department of AYUSH, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
,
Nibha Giri
4   State Homoeopathic Dispensary, Jakhanian, Ghazipur, Uttar Pradesh, India
› Author Affiliations Funding Nil.
› Further Information
    Permissions and Reprints

Abstract

Background Cancer (CA) is the second leading cause of death, accounting for one out of every six deaths worldwide. Chemotherapy and radiation treatments have unwanted effects and due to financial constraints are not available to a large portion of the population. Many CA patients turn to homoeopathy to improve their quality of life and to relieve pain caused by illness/conventional treatments.

Objective The review aims to appraise and summarise the findings of various in vitro CA cell line studies on homoeopathic medicines (HMs) and the detailed molecular mechanism behind the anti-CA effects of HMs.

Methods A systematic search was conducted on the major electronic biomedical database PubMed/MEDLINE for articles on homoeopathy and the CA cell line published between 25 June 2011 and 24 June 2021.

Result The searches identified 18 relevant articles. HMs showed cytotoxicity, increase in reactive oxygen species and decrease in mitochondrial membrane potential against CA cells while preserving normal cells. It interacts with deoxyribonucleic acid and up- and down-regulation of pro- and anti-apoptotic signalling proteins (p53, caspase-3 and Bax:B-cell lymphoma 2 [Bcl-2]), which all are involved in apoptosis. Increasing the treatment time of CA cells resulted in a higher percentage of cells in the G0/G1 phase (cell cycle arrest) and also showed inhibition of cell migration. HMs also had a complex effect on gene expression profiles.

Conclusion This review highlights preliminary laboratory evidence that HMs have therapeutic potential for combating the menace of carcinogenesis. More data are needed to show anti-tumour potential in the current setting and therapeutic value in battling CA.

Keywords

homoeopathy - cancer - cell line - tumour - cell cycle arrest - cytotoxicity - apoptosis - caspase - reactive oxygen species - gene expression

Authors' Contributions

A.K.D. was responsible for the concept, design, literature search, data extraction, analysis and preparation of the article. S.M. was involved in the concept, design, review and editing of the final manuscript, while D.J. and N.G. were responsible for data collecting and interpretation. The final article was edited, reviewed and approved by all of the contributors.




Publication History

Article published online:
24 May 2022

© 2022. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 World Health Organization. WHO Report on Cancer: Setting Priorities Investing Wisely and Providing Care for All. Geneva: WHO; 2020
    Google Scholar
  • 2 Sudhakar A. History of cancer, ancient and modern treatment methods. J Cancer Sci Ther 2009; 1 (02) 1-4
    CrossrefPubMedGoogle Scholar
  • 3 Hayden EC. Cutting off cancer's supply lines. Nature 2009; 458 (7239): 686-687
    CrossrefPubMedGoogle Scholar
  • 4 Ishiguro H, Kondo M, Hoshi SL. et al. Economic evaluation of intensive chemotherapy with prophylactic granulocyte colony-stimulating factor for patients with high-risk early breast cancer in Japan. Clin Ther 2010; 32 (02) 311-326
    CrossrefPubMedGoogle Scholar
  • 5 Milazzo S, Russell N, Ernst E. Efficacy of homeopathic therapy in cancer treatment. Eur J Cancer 2006; 42 (03) 282-289
    CrossrefPubMedGoogle Scholar
  • 6 Rossi E, Vita A, Baccetti S, Di Stefano M, Voller F, Zanobini A. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer 2015; 23 (06) 1795-1806
    CrossrefPubMedGoogle Scholar
  • 7 Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 2007; 6 (09) 1006-1010
    CrossrefPubMedGoogle Scholar
  • 8 Liu B, Chen Y, St Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med 2008; 44 (08) 1529-1535
    CrossrefPubMedGoogle Scholar
  • 9 Khan S, Nayak D, Khurana A, Manchanda RK, Tandon C, Tandon S. In vitro assessment of homeopathic potencies of Hydrastis canadensis on hormone-dependent and independent breast cancer. Homeopathy 2020; 109 (04) 198-206
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Şeker S, Güven C, Akçakaya H, Bahtiyar N, Akbaş F, Onaran İ. Evidence that extreme dilutions of paclitaxel and docetaxel alter gene expression of in vitro breast cancer cells. Homeopathy 2018; 107 (01) 32-39
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Wani K, Shah N, Prabhune A, Jadhav A, Ranjekar P, Kaul-Ghanekar R. Evaluating the anticancer activity and nanoparticulate nature of homeopathic preparations of Terminalia chebula. Homeopathy 2016; 105 (04) 318-326
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Casañas Pimentel RG, Robles Botero V, San Martín Martínez E, Gómez García C, Hinestroza JP. Soybean agglutinin-conjugated silver nanoparticles nanocarriers in the treatment of breast cancer cells. J Biomater Sci Polym Ed 2016; 27 (03) 218-234
    CrossrefPubMedGoogle Scholar
  • 13 Saha S, Bhattacharjee P, Mukherjee S. et al. Contribution of the ROS-p53 feedback loop in thuja-induced apoptosis of mammary epithelial carcinoma cells. Oncol Rep 2014; 31 (04) 1589-1598
    CrossrefPubMedGoogle Scholar
  • 14 Ahn KH, Yi KW, Park HT. et al. Anti-proliferative effect of Klimaktoplan® on human breast cancer cells. Arch Gynecol Obstet 2013; 288 (04) 833-838
    CrossrefPubMedGoogle Scholar
  • 15 Arora S, Aggarwal A, Singla P, Jyoti S, Tandon S. Anti-proliferative effects of homeopathic medicines on human kidney, colon and breast cancer cells. Homeopathy 2013; 102 (04) 274-282
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Khuda-Bukhsh AR, Mondal J, Shah R. Therapeutic potential of HIV nosode 30c as evaluated in A549 lung cancer cells. Homeopathy 2017; 106 (04) 203-213
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Mondal J, Samadder A, Khuda-Bukhsh AR. Psorinum 6 × triggers apoptosis signals in human lung cancer cells. J Integr Med 2016; 14 (02) 143-153
    CrossrefPubMedGoogle Scholar
  • 18 Saha S, Bhattacharjee P, Guha D. et al. Sulphur alters NFκB-p300 cross-talk in favour of p53-p300 to induce apoptosis in non-small cell lung carcinoma. Int J Oncol 2015; 47 (02) 573-582
    CrossrefPubMedGoogle Scholar
  • 19 Torres A, Vargas Y, Uribe D. et al. Pro-apoptotic and anti-angiogenic properties of the α /β-thujone fraction from Thuja occidentalis on glioblastoma cells. J Neurooncol 2016; 128 (01) 9-19
    CrossrefPubMedGoogle Scholar
  • 20 Arora S, Tandon S. DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by Ruta graveolens in human colon cancer cells. Homeopathy 2015; 104 (01) 36-47
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Nitzsche D, Melzig MF, Arlt VM. Evaluation of the cytotoxicity and genotoxicity of aristolochic acid I - a component of Aristolochiaceae plant extracts used in homeopathy. Environ Toxicol Pharmacol 2013; 35 (02) 325-334
    CrossrefPubMedGoogle Scholar
  • 22 Ghosh S, Bishayee K, Paul A. et al. Homeopathic mother tincture of Phytolacca decandra induces apoptosis in skin melanoma cells by activating caspase-mediated signaling via reactive oxygen species elevation. J Integr Med 2013; 11 (02) 116-124
    CrossrefPubMedGoogle Scholar
  • 23 Toliopoulos IK, Simos Y, Bougiouklis D, Oikonomidis S. Stimulation of natural killer cells by homoeopathic complexes: an in vitro and in vivo pilot study in advanced cancer patients. Cell Biochem Funct 2013; 31 (08) 713-718
    CrossrefPubMedGoogle Scholar
  • 24 Bishayee K, Mondal J, Sikdar S, Khuda-Bukhsh AR. Condurango (Gonolobus condurango) extract activates Fas receptor and depolarizes mitochondrial membrane potential to induce ROS-dependent apoptosis in cancer cells in vitro: CE-treatment on HeLa: a ROS-dependent mechanism. J Pharmacopuncture 2015; 18 (03) 32-41
    CrossrefPubMedGoogle Scholar
  • 25 Saha S, Hossain DMS, Mukherjee S. et al. Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit. BMC Complement Altern Med 2013; 13: 230
    CrossrefPubMedGoogle Scholar
  • 26 Preethi K, Ellanghiyil S, Kuttan G, Kuttan R. Induction of apoptosis of tumor cells by some potentiated homeopathic drugs: implications on mechanism of action. Integr Cancer Ther 2012; 11 (02) 172-182
    CrossrefPubMedGoogle Scholar
  • 27 Witt CM, Bluth M, Albrecht H, Weisshuhn TE, Baumgartner S, Willich SN. CM W. The in vitro evidence for an effect of high homeopathic potencies–a systematic review of the literature. Complement Ther Med 2007; 15 (02) 128-138
    CrossrefPubMedGoogle Scholar